Aspen Pharmacare Holdings Limited (APNHY) Research

Aspen Pharmacare Holdings Limited operates as a leading global pharmaceutical firm, specializing in the manufacturing and distribution of branded and niche medicinal products. The company's operations are segmented into two primary areas: Commercial Pharmaceuticals and Manufacturing. Its diverse product lineup includes general anesthetics, muscle relaxants, and topical agents, all offered under its "Anaesthetics" brand. Furthermore, Aspen provides a variety of injectable anticoagulants, particularly focusing on low molecular weight heparins, Xa inhibitors, and heparin derivatives, available through its "Thrombosis" brand. The company also markets a range of branded consumer, prescription, and over-the-counter (OTC) medications under regional names such as Circadin (a sleeping aid), Foxair (for respiratory conditions), Maltofer (an iron supplement), Mybulen (a pain reliever), and Zyloric (which helps inhibit uric acid production). In addition to its proprietary offerings, Aspen manufactures and supplies active pharmaceutical ingredients (APIs) and finished dosage forms to other companies. Founded in 1850, Aspen Pharmacare Holdings Limited maintains its corporate headquarters in Durban, South Africa.

Open Aspen Pharmacare Holdings Limited (APNHY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.